Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

The prevalence of neuropsychiatric disorders following traumatic brain injury (TBI) is 20%–50%, and disorders of mood and cognition may remain even after recovery of neurologic function is achieved. Selective serotonin reuptake inhibitors (SSRI) block the reuptake of serotonin in presynaptic cells t...

Full description

Bibliographic Details
Main Authors: John K. Yue, John F. Burke, Pavan S. Upadhyayula, Ethan A. Winkler, Hansen Deng, Caitlin K. Robinson, Romain Pirracchio, Catherine G. Suen, Sourabh Sharma, Adam R. Ferguson, Laura B. Ngwenya, Murray B. Stein, Geoffrey T. Manley, Phiroz E. Tarapore
Format: Article
Language:English
Published: MDPI AG 2017-07-01
Series:Brain Sciences
Subjects:
cognition
depression
meta-analysis
postconcussive disorder
selective serotonin reuptake inhibitor
sleep disturbance
traumatic brain injury
Online Access:https://www.mdpi.com/2076-3425/7/8/93

Internet

https://www.mdpi.com/2076-3425/7/8/93

Similar Items